Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Egypt.
Campus
Science
Patient Support
Products
Events
Login
Registration
Science
Cardiovascular
Diabetes
Rare Diseases
Vaccines
Asthma
Cardiovascular
Thrombosis
Hypertension
Dyslipidemia
Atherothrombosis
Diabetes
Sanofi's Insulin Legacy & Heritage
Time in Range
Patient Support
Cardiovascular
Diabetes
Atopic Dermatitis
Nasal Polyps
Asthma
Products
Clexane®
Soliqua®
Depakine®
Dapaglif®
Dupixent®
Toujeo®
Praluent®
Plavix®
Clexane®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
Proximal deep vein thrombosis
One day surgery & fast track surgery Thromboprophylaxis Guidelines
Soliqua®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Dapaglif®
Dapaglif®
Dapaglif®
Dupixent®
Dupixent Atopic Dermatitis
Dupixent® Asthma
Dupixent® Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Ocs Use
Type 2 Asthma With Comorbidities
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Toujeo®
Time in Range Results
OAD Uncontrolled Patients
Premix Uncontrolled Patients
Time In Range
Praluent®
Know about praluent
Plavix®
The Cure Study
PCI Cure Study
Plavix New Indication
Events
Guide Deep
Guide Wave 8
Campus
Science
Patient Support
Products
Events
Back to Main
Science
Cardiovascular
Diabetes
Rare Diseases
Vaccines
Asthma
Science
Cardiovascular
Thrombosis
Hypertension
Dyslipidemia
Atherothrombosis
Science
Diabetes
Sanofi's Insulin Legacy & Heritage
Time in Range
Back to Main
Patient Support
Cardiovascular
Diabetes
Atopic Dermatitis
Nasal Polyps
Asthma
Back to Main
Products
Clexane®
Soliqua®
Depakine®
Dapaglif®
Dupixent®
Toujeo®
Praluent®
Plavix®
Products
Clexane®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
Proximal deep vein thrombosis
One day surgery & fast track surgery thromboprophylaxis Guidelines
Products
Soliqua®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Products
Dapaglif®
Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
Products
Dupixent®
Dupixent Atopic Dermatitis
Dupixent® Asthma
Dupixent®
Dupixent® Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Mixed Biomarkers
Type 2 Asthma With Comorbidities
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Products
Toujeo®
Time in Range Results
OAD Uncontrolled Patients
Premix Uncontrolled Patients
Time In Range
Products
Praluent®
Know about praluent
Products
Plavix®
The Cure Study
PCI Cure Study
Plavix New Indication
Back to Main
Events
Guide Deep
Guide Wave 8
Login
Registration
Home
Science
Cardiovascular
Atherothrombosis
Insights and impacts from the HOST-EXAM trial
Prof. Capodanno Host Exam
Insights and Impacts From the Host-exam Trial.
Related articles
Insights and impacts from the TALOS-AMI trial
Insights and impacts from the TALOS-AMI trial
Learn more
MAT-EG-2200264
To continue reading confirm that you are a healthcare professional
Login
